Astrana Health (ASTH) director option exercise and tax sale disclosed

Rhea-AI Filing Summary

Astrana Health director David Schmidt reported exercising stock options and related share withholding. On January 13, 2026, he exercised 20,000 stock options with an exercise price of $5.79 per share, receiving the same number of Astrana Health common shares.

On the same date, 4,269 common shares were withheld at a price of $27.12 in a transaction coded "F," typically reflecting shares withheld to cover taxes. After these transactions, Schmidt directly owned 31,494 common shares, which include 6,449 shares of restricted stock scheduled to vest on the earlier of June 11, 2026 or the issuer's 2026 annual stockholder meeting. The exercised option position was reduced to 0 derivative securities.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schmidt David

(Last) (First) (Middle)

C/O ASTRANA HEALTH, INC.

1668 S. GARFIELD AVE, 2ND FLOOR

(Street)

ALHAMBRA CA 91801

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Astrana Health, Inc. [ ASTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/13/2026		M		20,000	A	$5.79	35,763	D
Common Stock	01/13/2026		F		4,269	D	$27.12	31,494(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to Buy)	$5.79	01/13/2026		M			20,000	(2)	02/14/2026	Common Stock	20,000	$0	0	D

Explanation of Responses:

1. Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.

2. These stock options were fully vested and exercisable.

	/s/ Kathy Diep, as Attorney-in-Fact	01/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Astrana Health (ASTH) report for David Schmidt?

Director David Schmidt exercised 20,000 stock options at an exercise price of $5.79 per share on January 13, 2026, receiving 20,000 Astrana Health common shares.

How many Astrana Health (ASTH) shares were withheld for taxes in this Form 4?

The Form 4 shows a transaction coded "F" on January 13, 2026 in which 4,269 common shares were disposed of at a price of $27.12, reflecting shares withheld, commonly for tax obligations.

How many Astrana Health (ASTH) shares does David Schmidt own after the reported transactions?

Following the reported transactions, David Schmidt directly beneficially owned 31,494 shares of Astrana Health common stock, as indicated in the Form 4.

What happened to David Schmidt’s Astrana Health stock options in this filing?

The filing shows a stock option (right to buy) for 20,000 shares with a $5.79 exercise price, coded "M" on January 13, 2026. These options were fully vested and exercisable and, after exercise, the number of derivative securities beneficially owned was 0.

Does David Schmidt hold restricted Astrana Health (ASTH) stock, and when does it vest?

Yes. A footnote states that his holdings include 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of Astrana Health’s 2026 annual meeting of stockholders.

What is David Schmidt’s role at Astrana Health (ASTH) according to the Form 4?

The Form 4 identifies David Schmidt as a director of Astrana Health, Inc. and indicates the report is filed by one reporting person.